Category: General Biotechnology

Branding Biotech – Communicating the Brand’s Point of Differentiation

This is a guest post from Brannon Cashion, President of Addison Whitney Health. Do you have a response to Brannin’s post? Respond in the comments section below. The branding process in the biotech sector can be related to the oxymoronic term of “new and improved.” While there is great benefit to being new, and also to […]



Drug Patent Expirations for Aug 18, 2016

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. KALETRA (lopinavir; ritonavir) Abbvie Patent number: 6,284,767 Expiration Date: Aug 15, 2016 TESTODERM (testosterone) Alza Patent number: 5,840,327 Expiration Date: Aug 15, 2016 ENABLEX (darifenacin hydrobromide) […]



Drug Patent Expirations for Aug 11, 2016

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. KAZANO (alogliptin benzoate; metformin hydrochloride) Takeda Pharms Usa Patent number: 6,303,640 Expiration Date: Aug 9, 2016 DUETACT (glimepiride; pioglitazone hydrochloride) Takeda Pharms Usa Patent number: 6,303,640 […]



Drug Patent Expirations for Aug 4, 2016

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. XERESE (acyclovir; hydrocortisone) Valeant Bermuda Patent number: RE 39,264 Expiration Date: Aug 2, 2016 TAMIFLU (oseltamivir phosphate) Roche Patent number: 5,866,601 Expiration Date: Aug 2, 2016 […]



Will Brexit Actually Happen?

Following two posts on Brexit and British biotechnology, I would like to provide a perspective that turns everything on its head. It seems increasingly unlikely that Brexit will actually take place. The rationale for this argument has nothing to do with Britons having second thoughts, but is based on economic and legal arguments. Firstly, the […]



Brexit and British Biotech; A Second Look from ESOF

In the wake of my recent post on the potential impact of Brexit on British Biotechnology, I am fortunate to be at the European Science Open Forum (ESOF). The EuroScience Open Forum (ESOF) is a biennial, pan-European, general science conference dedicated to scientific research and innovation. It is similar in scope to the AAAS conference in […]



Drug Patent Expirations for Jul 21, 2016

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. VALTREX (valacyclovir hydrochloride) Glaxosmithkline Patent number: 6,107,302 Expiration Date: Jul 19, 2016 VALTREX (valacyclovir hydrochloride) Glaxosmithkline Patent number: 5,879,706 Expiration Date: Jul 19, 2016 POMALYST (pomalidomide) […]



Brexit and British Biotech

I have a tool that can be used to measure the impact of Brexit on biotechnology in the United Kingdom. I have been measuring global biotechnology for eight years and my objective data-driven metrics provide both a baseline to gauge future directions, and guidance for how to improve the sector’s performance. Eight years ago I […]



Drug Patent Expirations for Jul 14, 2016

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. CIALIS (tadalafil) Lilly Patent number: 6,140,329 Expiration Date: Jul 11, 2016 ZEGERID (omeprazole; sodium bicarbonate) Santarus Inc Patent number: 5,840,737 Expiration Date: Jul 15, 2016 ZEGERID […]



Drug Patent Expirations for Jul 7, 2016

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. CRESTOR (rosuvastatin calcium) Ipr Patent number: RE 37,314 Expiration Date: Jul 8, 2016 DrugPatentWatch provides instant access to actionable insights on pharmaceutical drugs. For more information […]



%d bloggers like this: